Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Triamcinolone acetonide 55microgram aqueous nasal spray (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mometasone furoate monohydrate 0.05% aqueous nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 1 mg/g oromucosal paste |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone creams (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely hydrocortisone 25 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone 1 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone ointments |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely hydrocortisone 25 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate 10 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Crotamiton 100 mg/g and hydrocortisone 2.5 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone 10 mg/g and urea 100 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clioquinol 30 mg/g and hydrocortisone 10 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone 10 mg/g and oxytetracycline (as oxytetracycline hydrochloride) 30 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely hydrocortisone acetate 10 milligram/1 gram and sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fusidic acid 20 milligram/1 gram and hydrocortisone acetate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Econazole nitrate 10 mg/g and hydrocortisone 10 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone 10 mg/g and miconazole nitrate 20 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely hydrocortisone 10 milligram/1 gram and miconazole nitrate 20 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely clotrimazole 10 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alclometasone dipropionate 0.05% cream (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alclometasone dipropionate 500 microgram/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Beclometasone dipropionate 250 microgram/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone valerate 0.12% foam (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone 0.1% scalp application (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone 0.1% cream (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone 0.1% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone 0.1% lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone+salicylic acid 0.05/3% scalp application |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone 0.05% cream (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone+neomycin sulfate 0.1/0.5% ointment (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely clobetasone butyrate 500 microgram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clobetasone butyrate 500 microgram/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Desoxymethasone 0.05% oily cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diflucortolone valerate 1 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diflucortolone valerate 0.1% oily cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diflucortolone valerate 1 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diflucortolone valerate 0.3% oily cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diflucortolone valerate 0.3% ointment (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluocinolone acetonide 62.5 microgram/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluocinolone acetonide 0.00625% cream (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluocinolone acetonide 25 microgram/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluocinolone acetonide 250 microgram/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluocortolone 0.5% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluocortolone 0.5% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fludroxycortide 125 microgram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fludroxycortide 125 microgram/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely halcinonide 1 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone butyrate 1 mg/g cutaneous emulsion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone butyrate 1 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone butyrate 0.1% lipocream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone butyrate 0.1% scalp lotion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide+chlortetracycline hydrochloride 0.1/3% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mometasone furoate 1 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mometasone furoate 1 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely mometasone furoate 1 milligram/1 gram conventional release cutaneous lotion (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluticasone propionate 0.05% cream (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluticasone propionate 50 microgram/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone+clotrimazole 0.05/1% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Beclomethasone dipropionate+salbutamol (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing betamethasone and clioquinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone- and clotrimazole-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing betamethasone and fusidic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone+neomycin sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing betamethasone and salicylic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clobetasol propionate+neomycin sulfate+Nystatin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing clobetasone butyrate and neomycin sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clobetasone butyrate+oxytetracycline+nystatin (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fusidic acid- and hydrocortisone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Gentamicin- and hydrocortisone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing hydrocortisone and pramocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing hydrocortisone and sodium fusidate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clorquinaldol- and hydrocortisone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chloramphenicol- and hydrocortisone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing clioquinol and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing clotrimazole and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing crotamiton and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing dimeticone and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing econazole and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone- and lidocaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing hydrocortisone and miconazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticosterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|